Suchergebnisse - "Lewis, K D"

PubPharm (39)

1

Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Lewis, K. | Peris, K. | Sekulic, A. | +22

2

Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation-positive melanoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Robert, C. | Lewis, K. | Gutzmer, R. | +14

3

Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200) : updated overall survival data after >5 years of follow-up

enthalten in: ESMO open | 2021

von D'Angelo, S. | Bhatia, S. | Brohl, A. | +12

4

Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma : 42-month analysis of the phase II randomized, double-blind BOLT study

enthalten in: The British journal of dermatology | 2020

von Dummer, R. | Guminksi, A. | Gutzmer, R. | +14

CommentIn: Br J Dermatol. 2020 Jun;182(6):1322-1323. - PMID 31849041

5

Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation-positive melanoma receiving adjuvant vemurafenib

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Ascierto, P. | Lewis, K. | Di Giacomo, A. | +14

CommentIn: Ann Oncol. 2020 Jan;31(1):11-12. - PMID 31912783

6

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma : 42‐month analysis of the phase II randomized, double‐blind BOLT study

enthalten in: British Journal of Dermatology | 2020

von Dummer, R. | Guminksi, A. | Gutzmer, R. | +14

7

Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma : 30-month analysis of the randomized phase 2 BOLT study

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2018

von Lear, J. | Migden, M. | Lewis, K. | +17

8

A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer

enthalten in: Investigational new drugs | 2013

von Dasari, A. | Gore, L. | Messersmith, W. | +7

9

Vismodegib in basal cell carcinoma

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2012

von Amaria, R. | Bowles, D. | Lewis, K. | +1

10

A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer

enthalten in: Investigational new drugs | 2012

von Dasari, A. | Gore, L. | Messersmith, W. | +7